1. Home
  2. HALO vs AIT Comparison

HALO vs AIT Comparison

Compare HALO & AIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$107.93

Market Cap

12.0B

Sector

Health Care

ML Signal

N/A

Logo Applied Industrial Technologies Inc.

AIT

Applied Industrial Technologies Inc.

N/A

Current Price

$339.75

Market Cap

12.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
AIT
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
12.5B
IPO Year
2001
1994

Fundamental Metrics

Financial Performance
Metric
HALO
AIT
Price
$107.93
$339.75
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
$99.56
★ $400.00
AVG Volume (30 Days)
★ 2.0M
211.9K
Earning Date
11-02-2026
10-27-2026
Dividend Yield
N/A
★ 0.61%
EPS Growth
N/A
★ 8.20
EPS
3.11
★ 10.95
Revenue
★ $151,862,000.00
$21,485,000.00
Revenue This Year
$32.72
$5.87
Revenue Next Year
$10.61
$5.84
P/E Ratio
$36.16
★ $30.78
Revenue Growth
★ N/A
N/A
52 Week Low
$61.23
$238.34
52 Week High
$116.85
$374.80

Technical Indicators

Market Signals
Indicator
HALO
AIT
Relative Strength Index (RSI) 54.81 53.11
Support Level $104.49 $331.42
Resistance Level $111.15 $345.48
Average True Range (ATR) 3.04 6.73
MACD -0.71 2.05
Stochastic Oscillator 42.53 73.18

Price Performance

Historical Comparison
HALO
AIT

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

Share on Social Networks: